Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/14/2012US8242150 Triazole derivatives for treating alzheimer'S disease and related conditions
08/14/2012US8242149 Modulators of ATP-binding cassette transporters
08/14/2012US8242148 Treatment methods employing histamine H3 receptor antagonists, including betahistine
08/14/2012US8242147 Aryl ureas with angiogenisis inhibiting activity
08/14/2012US8242146 Administering ROFLUMILAS and DICLOFENAC; antiinflammatory agents
08/14/2012US8242145 Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors
08/14/2012US8242144 Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
08/14/2012US8242143 Thiazolyl mGluR5 antagonists and methods for their use
08/14/2012US8242142 Cyclohexylamines, phenylamines and uses thereof
08/14/2012US8242140 Viral polymerase inhibitors
08/14/2012US8242139 Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
08/14/2012US8242138 Amidine-containing compounds useful as muscarinic receptor antagonists
08/14/2012US8242137 Crystalline forms of a biphenyl compound
08/14/2012US8242136 Use of glucosidase inhibitors for therapy of mucovisidosis
08/14/2012US8242135 Biphenyl derivatives
08/14/2012US8242134 Isoquinolinone derivatives as NK3 antagonists
08/14/2012US8242133 Arthropod pest control compositions comprising substituted oxazolo [5,4-b ] pyridines
08/14/2012US8242132 Methods and compositions for alleviating stuttering
08/14/2012US8242131 Methods of treating middle-of-the-night insomnia
08/14/2012US8242130 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
08/14/2012US8242129 6-phenylpyrimidinones as PIM modulators
08/14/2012US8242128 1,3-benzoxazolyl derivatives as kinase inhibitors
08/14/2012US8242127 Derivatives of pyrimido[6,1-A]isoquinolin-4-one
08/14/2012US8242126 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
08/14/2012US8242125 Heterobicyclic carboxamides as inhibitors for kinases
08/14/2012US8242124 Diketopiperidine derivatives as HIV attachment inhibitors
08/14/2012US8242123 Insecticidal methods using 4-amino-5-chloro-thieno[2,3-d]-pyrimidine compounds
08/14/2012US8242122 Method and compounds for inhibition of cell death
08/14/2012US8242121 Pyridyl piperidine orexin receptor antagonists
08/14/2012US8242119 Protease inhibitors
08/14/2012US8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
08/14/2012US8242117 5-membered heterocycle-based p38 kinase inhibitors
08/14/2012US8242116 Fused thiazole derivatives as kinase inhibitors
08/14/2012US8242115 Materials and methods to potentiate cancer treatment
08/14/2012US8242114 Bonding tissues and cross-linking proteins with naphthalimide compounds
08/14/2012US8242113 Oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone pharmaceutical compositions thereof
08/14/2012US8242112 Heterocyclic aspartyl protease inhibitors
08/14/2012US8242111 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
08/14/2012US8242110 Use of antihistamine agents for the preventive or early treatment of inflammatory syndromes, in particular those triggered by togaviruses
08/14/2012US8242108 Cell migration modulating compounds
08/14/2012US8242107 Diazepane-acetamide derivatives as selective 11β-HSD1 inhibitors
08/14/2012US8242106 Toll-like receptor agonist formulations and their use
08/14/2012US8242105 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof
08/14/2012US8242104 Benzoxazepin P13K inhibitor compounds and methods of use
08/14/2012US8242103 Sulphamides for treatment of cancer
08/14/2012US8242102 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
08/14/2012US8242101 Leukemia treatment method and composition
08/14/2012US8242100 Compositions and methods for inducing bone growth and inhibiting bone loss
08/14/2012US8242099 Implants and methods for treating inflammation-mediated conditions of the eye
08/14/2012US8242098 Methods of treating hormone-related conditions using thio-oxindole derivatives
08/14/2012US8242097 Cosmetic use of polysaccharide compounds containing non-polymer siloxane graft(s)
08/14/2012US8242096 Compositions comprising pectin and ascorbic acid
08/14/2012US8242094 siRNA of NF-kB p105 for inhibiting cell proliferation and migration and a composition comprising same
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8242090 Vascular therapeutics
08/14/2012US8242089 Sphingolipids polyalkylamine conjugates for use in transfection
08/14/2012US8242087 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents
08/14/2012US8242086 Methods and compositions for treating disorders caused by a deficiency in a gene product of a CLN gene
08/14/2012US8242085 Tetrahydrofuro [3,4-D] dioxolane compounds for use in the treatment of viral infections and cancer
08/14/2012US8242079 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
08/14/2012US8242055 Herbicidally and insecticidally active phenyl-substituted pyridazinones
08/14/2012US8241899 Anti-TNF antibodies, compositions, methods and uses
08/14/2012US8241888 microorganism capable of making an isoprenoid by changing the carbon flux through geranyl pyrophosphate, farnesyl pyrophosphate, or geranylgeranyl pyrophosphate and synthesis of isopentenyl pyrophosphate from an isoprenoid pathway; production of farnesol and geranylgeraniol
08/14/2012US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
08/14/2012US8241684 Preventive and/or therapeutic agent for inflammatory bowel diseases
08/14/2012US8241669 Endoparasiticidal gel composition
08/14/2012US8241667 Dual controlled release osmotic device
08/14/2012US8241664 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
08/14/2012US8241663 Liposome preparation
08/14/2012US8241662 Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy
08/14/2012US8241660 Patch for the expulsion of insect poison from the skin after stings from membranous insects (hymenoptera)
08/14/2012US8241659 Nutrition with lipids and non-digestible saccharides
08/14/2012US8241649 Dermatological/cosmetic gels comprising at least one retinoid and/or retinoid salt and benzoyl peroxide
08/14/2012US8241620 Complex polymere amphiphile-PDGF
08/14/2012US8241619 Hindered amine nitric oxide donating polymers for coating medical devices
08/14/2012US8241615 Water-resistant sunscreen composition
08/14/2012US8241269 Fluid medication delivery device
08/14/2012US8239978 Vision through photodynamic therapy of the eye
08/14/2012CA2740247A1 4-hydroxybutyric acid analogs
08/14/2012CA2732479A1 4-hydroxybutyric acid analogs
08/14/2012CA2710182C Pyrimidyl indoline compound
08/14/2012CA2684571C Novel therapeutic uses of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine
08/14/2012CA2661062C Compositions comprising calcium citrate malate and methods for making the same
08/14/2012CA2635311C Naphthalenedione compounds
08/14/2012CA2632078C Methods of inducing terminal differentiation
08/14/2012CA2628193C Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
08/14/2012CA2597624C 2-methylene-19-nor-(20s-24s)-1.alpha.,25-dihydroxyvitamin-d2
08/14/2012CA2574829C Bicyclic amides as kinase inhibitors
08/14/2012CA2562075C Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
08/14/2012CA2559974C Compositions and methods for reducing or preventing obesity
08/14/2012CA2558135C Aqueous composition comprising thiazole derivative
08/14/2012CA2552855C Azabicyclooctan-3-one derivatives and use thereof
08/14/2012CA2544649C Morpholine derivatives as norepinephrine reuptake inhibitors
08/14/2012CA2537665C Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
08/14/2012CA2530460C Method of treating acute coronary syndromes
08/14/2012CA2527496C 4-substituted derivatives of pyrazolo [3,4-d] pyrimidine and pyrrolo [2,3-d] pyrimidine and uses thereof
08/14/2012CA2524979C Solid dosage form comprising (s)-pantoprazole magnesium salt
08/14/2012CA2523079C Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
08/14/2012CA2520628C T-type calcium channel blocker
08/14/2012CA2514971C Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
1 ... 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 ... 7860